Moller Wealth Partners’s AbbVie ABBV Stock Holding History

Moller Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,554	Closed	-$643K	–	69
2026 Q2	$643K	Buy	+2,554	New	+$549K	0.12%	42
2019 Q2	–	Sell	-7,126	Closed	-$604K	–	51
2019 Q1	$604K	Hold	7,126	–	–	0.27%	33
2018 Q4	$604K	Buy	+7,126	New	+$627K	0.39%	38
2017 Q4	–	Sell	-3,493	Closed	-$253K	–	48
2017 Q3	$253K	Hold	3,493	–	–	0.1%	39
2017 Q2	$253K	Buy	+3,493	New	+$235K	0.11%	39
2014 Q4	–	Sell	-7,522	Closed	-$434K	–	44
2014 Q3	$434K	Hold	7,522	–	–	0.2%	38
2014 Q2	$425K	Hold	7,522	–	–	0.19%	40
2014 Q1	$387K	Buy	7,522 +3,493	+87%	+$177K	0.2%	39
2013 Q4	$213K	Buy	+4,029	New	+$198K	0.11%	45

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Moller Wealth Partners's ABBV Position: Q3 2026 in Review

Moller Wealth Partners sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 2,554 shares — an estimated $643K sold.

Moller Wealth Partners first reported a position in ABBV in Q4 2013 and held it in 9 quarters. The position peaked at $643K in Q2 2026. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Moller Wealth Partners reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
Moller Wealth Partners sold 2,554 AbbVie shares in Q3 2026, an estimated $643K.
Moller Wealth Partners first reported a position in AbbVie in Q4 2013 and held it in 9 quarters.
Moller Wealth Partners's AbbVie position peaked at $643K in Q2 2026.
1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Moller Wealth Partners's 13F filing for Q3 2026, filed 15 Oct 2026.